Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • Fosun Pharma sells 6% stake in Gland Pharma for ₹2,800 crore; three mutual funds pick up shares
    • Sebi Proposes Net Settlement Of Cash Market Trades For Mutual Funds
    • The Only Account the IRS Never Taxes Going In, Growing, or Coming Out: 3 ETFs That Belong Inside It
    • Sebi proposes net settlement of funds for mutual fund cash market trades
    • Kotak Multi Asset Allocation Fund in Focus as Multi-Asset Strategies Gain Attention Amid Changing Markets
    • SEBI proposes net settlement of funds for mutual fund cash-market trades
    • Treasury ETFs aren’t bleeding out, they’re reshuffling: what the flows actually tell us
    • Wall Street just poured nearly $900 million into Bitcoin and Ethereum ETFs
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Mutual Funds»Motilal Oswal Mutual Fund buys additional shares of Coforge worth ₹231 crore
    Mutual Funds

    Motilal Oswal Mutual Fund buys additional shares of Coforge worth ₹231 crore

    April 18, 2025


    Motilal Oswal Mutual Fund (MF) on Thursday acquired additional shares of IT firm Coforge worth ₹231 crore through an open market transaction.

    According to the bulk deal data available on the NSE, Motilal Oswal MF purchased 3.5 lakh shares or 0.52 per cent stake in Greater Noida-based Coforge.

    The shares were acquired at an average price of ₹6,605.13 apiece, taking the transaction value to ₹231.18 crore.

    After the latest transaction, Motilal Oswal MF’s equity stake in Coforge rose to 8.58 per cent from 8.06 per cent.

    Details of the seller(s) of Coforge’s shares could not be ascertained on the National Stock Exchange (NSE).

    The scrip of Coforge on Thursday climbed 3.78 per cent to close at Rs 6,650 per piece on the NSE.

    On Thursday, Coforge said its wholly-owned subsidiary Coforge Technologies Australia has completed the acquisition of TMLabs from its shareholders in accordance with the share sale agreement.

    Published on April 18, 2025



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    Fosun Pharma sells 6% stake in Gland Pharma for ₹2,800 crore; three mutual funds pick up shares

    September 4, 2026

    Sebi Proposes Net Settlement Of Cash Market Trades For Mutual Funds

    September 4, 2026

    Sebi proposes net settlement of funds for mutual fund cash market trades

    September 4, 2026
    Leave A Reply Cancel Reply

    Top Posts

    The Shifting Landscape of Art Investment and the Rise of Accessibility: The London Art Exchange

    September 11, 2023

    Charlie Cobham: The Art Broker Extraordinaire Maximizing Returns for High Net Worth Clients

    February 12, 2024

    The Only Account the IRS Never Taxes Going In, Growing, or Coming Out: 3 ETFs That Belong Inside It

    September 4, 2026

    The Unyielding Resilience of the Art Market: A Historical and Contemporary Perspective

    November 19, 2023
    Don't Miss
    Mutual Funds

    Fosun Pharma sells 6% stake in Gland Pharma for ₹2,800 crore; three mutual funds pick up shares

    September 4, 2026

    Shares of Gland Pharma were in focus on Friday, September 4, after promoter Fosun Pharma…

    Sebi Proposes Net Settlement Of Cash Market Trades For Mutual Funds

    September 4, 2026

    The Only Account the IRS Never Taxes Going In, Growing, or Coming Out: 3 ETFs That Belong Inside It

    September 4, 2026

    Sebi proposes net settlement of funds for mutual fund cash market trades

    September 4, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    The truth behind the 12-14% returns in bonds – Economy Explained News

    September 26, 2025

    Local Government Commission approves millions in bonds for New Hanover, Pender counties

    August 6, 2024

    FMCX: First Manhattan’s Debut Active ETF Is Too Expensive (NYSEARCA:FMCX)

    August 27, 2024
    Our Picks

    Fosun Pharma sells 6% stake in Gland Pharma for ₹2,800 crore; three mutual funds pick up shares

    September 4, 2026

    Sebi Proposes Net Settlement Of Cash Market Trades For Mutual Funds

    September 4, 2026

    The Only Account the IRS Never Taxes Going In, Growing, or Coming Out: 3 ETFs That Belong Inside It

    September 4, 2026
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    ₹9000 monthly SIP can help you retire at 45 with ₹2 lakh monthly pension

    May 5, 2026
    © 2026 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.